News

Bioidentical hormones have been shown to decrease and prevent the risk of Alzheimer’s, osteoporosis and heart disease, which parallels the increased risk that comes with aging. Should you be offering HRT to your patients?

With 4 decades of dermatology advances, we asked the very dermatologist experts who we often contact to help us to report on the milestones to weigh in on what they think have made the most difference in theirs and their patients’ lives.

Bioidentical hormones have been shown to increase skin hydration and reduce skin atrophy. Dr. Ronald Moy discusses the benefits - and the hormones themselves - in the context of the aesthetic practice. 

As age is the strongest risk factor in NMSC, dermatologists can see an increase in this type of cancer in elderly patients, and treatment preferences vary.  

Over the past 40 years, there have been major dermatological breakthroughs that have changed the way doctors treat patients, along with the very treatments they use. 

Changes in government medical billing and coding for dermatologists and other physicians is scheduled to begin January 2021. 

Study examines effectiveness of hyaluronic acid with 0.3% lidocaine to correct volume loss in patients seeking hand rejuvenation.

Dermatologists investigate better ways to treat radiodermatitis as it becomes increasingly common in breast cancer patients. 

It is well established that psoriasis is associated with cardiometabolic disease, though the reason why remains unclear. This study followed pregnant women and mothers with psoriasis over an 11 year period to gain insight into the link between the immune-mediated skin disease and cardiometabolic disease.

Comparative diagnosis of actinic keratosis (AK) and squamous cell carcinoma (SCC) in situ is needed for accuracy in treatment plan.

Dr. Day presents her best tips on approaching social media channels as a tool to engage with potential patients, knowing your audience and sharing the latest science and trends in dermatology. 

Dr. Torres explores continuing medical education programs and whether they're successful in helping physicians obtain new knowledge.

Niki Vora reflects on how her struggles with untreated atopic dermatitis, folliculitis and cystic acne led her to writing her scholarship-winning essay. 

The Prior Authorizations process creates inconsistent application, physician dissatisfaction and opportunity for life-threatening adverse events for patients.

In this Legal Eagle article, Dr. Goldberg discusses the intricacies of the physician-patient relationship, and how that relationship can still be formed even if you never see the patient.

Today, the U.S. Food and Drug Administration approved the topical retinoid trifarotene 0.005% (AKLIEF, Galderma) for the treatment of acne vulgaris. 

Study compares the effectiveness of petrolatum-based ointment vs. silicone gel for skin healing post fractional ablative erbium laser resurfacing.

Topicals aimed at reviving estrogen-deficient skin and warding off damage from UV rays hours after exposure, while repairing DNA, are among the new cosmeceutical innovations backed by science.

Although most skincare innovations happen in the medically dispensed lines before mass market availability, Dr. Vivian Bucay points out that there are lower priced options backed by science that dermatologists can confidently recommend to patients looking for effective skincare products.

Psoriasis and atopic dermatitis patients want more nonsteroidal topical options. This expert breaks down newly available treatments and those to come.

Are there effective hyperhidrosis treatments that patients can better afford and tolerate? Dr. Jisun Cha discusses practical points of diagnosis and treatment.

Are your patients happy with their current acne treatment? These five new therapeutic options could offer better results, according to several studies.

Recognizing the role of stress in skin disease can allow dermatologists to empower their patients to pursue any and all avenues for managing their disease.

In recognition of the first anniversary of our Innovation column, Drs. Steve Xu and William Ju reflect on the range of topics covered throughout the year and highlight what's to come.

Dean Celia, our original managing editor, reflects the beginning of Dermatology Times and the medical editors, Dr. Ronald Wheeland and Dr. Norman Levine,  who ensured the publication focused on the key industry developments that mattered most to practicing dermatologists.

About Face: Navigating Neuromodulators and Injection Techniques for Optimal Results

A recent study discovered that body mass index (BMI) and age of disease onset may play a part in the development of hypertension in psoriatic arthritis and psoriasis. Read what researchers found in this article.

Because nobody wants unhappy patients. Learn how to help yours avoid procedure regret from a few of these RealSelf patient stories.